| CAT # |
Product Name |
Description |
| CPDM400228 |
8-bromo-5-chloro-[1,2,4]triazolo[4,3-c]pyrimidine |
|
| CPD107768 |
Icotinib HCl；BPI2009 |
Icotinib Hydrochloride (BPI-2009) is an effective and selective EGFR inhibitor |
| CPD113409 |
SGR 1505 |
SGR-1505 is an orally active MALT1 allosteric inhibitor. |
| CPD111306 |
7-bromo-2,4,6-trichloro-8-fluoroquinazoline |
|
| CPD113109 |
ARS-1323-Alkyne |
ARS-1323-alkyne, a switch-II pocket (S-IIP) inhibitor |
| CPDP801183 |
VVD-214;RO7589831;VVD-133214 |
VVD-214 is a synthetic WRN helicase lethal allosteric inhibitor. |
| CPDP801366 |
Inlexisertib;DCC-3116 |
DCC-3116 is an orally active ULK1/2 inhibitor. |
| CPDA601378 |
Nonylacridine Orange |
|
| CPD112537 |
4H-1,3-Dioxolo[4,5-c]pyrrole-4-carboxylic acid,... |
|
| CPDP801763 |
MC3138 |
MC3138 is a selective SIRT5 activator. |
| CPDP801758 |
Chk1-IN-6 |
Chk1-IN-6 is a potent, selective, and orally bioavailable CHK1 candidate inhibitor. |
| CPD113410 |
NDI-101150 |
NDI-101150 is a potent and selective inhibitor of HPK1 (hematopoietic progenitor cell kinase 1). |
| CPDA601453 |
BMS-986408 |
BMS-986408 is an orally effective dual DGK α/Zeta inhibitor. |
| CPDA601445 |
AZD0780;EX-A6975;laroprovstatum; laroprovstat |
PCSK9-IN-12 is a heteroaromatic compound. PCSK9-IN-12 has binding affinity for PCSK9 with a Kd value<200 nM. PCSK9-IN-12 can be used for the study of cholesterol metabolism. |
| CPDA601447 |
PF07328948 |
PF-07328948 is an orally effective BDK (branched chain ketone dehydrogenase kinase) inhibitor. |
| CPD112881 |
(1S)-2,2,2-trifluoro-1-methylethyl]hydrazine hy... |
|
| CPD108261 |
LOXO-305;LY 3527727;Pirtobrutinib |
Pirtobrutinib (LOXO-305) is a highly selective and non covalent next-generation BTK inhibitor that can inhibit various BTK C481 substitution mutations. |
| CPD115335 |
Luxdegalutamide; ARV-766 |
Luxdegalutamide (ARV-766) is an orally effective protein hydrolysis targeted chimeric (PROTAC) targeting androgen receptor (AR), which can degrade AR resistance related mutants. |
| CPDA601356 |
iHSP110-33 |
|
| CPDP800487 |
TNG462 |
TNG-462 is an orally effective selective PRMT5 inhibitor. |
| CPDP801649 |
1,2,4-Triazolo[4,3-c]pyrimidine-5,8-diamine, N5... |
EED ligand 1 is a diverse and effective inhibitor that targets the EED subunit of methyltransferase PRC2. |
| CPDM400208 |
6,7-Difluoro-4(3H)-quinazolinone |
|
| CPDP801752 |
N-(4-quinolinylcarbonyl)Glycine |
|
| CPDM400190 |
Methyl 5-bromo-2-methyl-3-(trifluoromethyl)benz... |
|
